Skip Navigation LinksHome > September/October 2013 - Volume 37 - Issue 5 > Natalizumab (Tysabri)-Associated Progressive Multifocal Leuk...
Journal of Computer Assisted Tomography:
doi: 10.1097/RCT.0b013e318298aa0d

Natalizumab (Tysabri)-Associated Progressive Multifocal Leukoencephalopathy: Insights From Perfusion Magnetic Resonance Imaging

Elster, Martha J. BA

Collapse Box


Abstract: A case of natalizumab-associated progressive multifocal leukoencephalopathy in a 38-year-old woman is presented showing characteristics on magnetic resonance imaging (MRI) with high signal on T2-weighted images and patchy contrast enhancement. After 5 days of plasma exchange therapy, contrast enhancement decreased, but the abnormality on T2-weighted images increased. Perfusion MRI at this time demonstrated significantly increased blood flow to the lesion. Thirteen days after initiation of treatment, perfusion MR returned to normal in advance of significant anatomical changes on conventional MRIs. This case suggests that MR perfusion imaging may be helpful in monitoring the treatment of patients with natalizumab-associated progressive multifocal leukoencephalopathy.

© 2013 by Lippincott Williams & Wilkins



Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.